Sentinel Lymph Node Biopsy in Breast Cancer: A Comprehensive Literature Review

Journal of Surgical Education

Volumn 66, Issue 5, 2009, Pages 267-275

  Salem, Ahmed ^a  

^a Department of Surgery   (Jordan)

Author keywords

axillary; biopsy; breast; cancer; extra axillary; Medical Knowledge; Patient Care; Practice Based Learning and Improvement; sentinel; Systems Based Practice

Indexed keywords

ISOSULFAN BLUE; METHYLENE BLUE;

ANAPHYLAXIS; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HYPOTENSION; IMMUNOHISTOCHEMISTRY; INTERNAL MAMMARY ARTERY; INTRADUCTAL CARCINOMA; ISOTOPE LABELING; LUNG EDEMA; LYMPH NODE METASTASIS; MASTECTOMY; MICROMETASTASIS; MORBIDITY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; SENTINEL LYMPH NODE BIOPSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL TECHNIQUE; TREATMENT INDICATION;

AXILLA; BIOPSY, NEEDLE; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 71549142562     PISSN: 19317204     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsurg.2009.07.011     Document Type: Article

References (77)

1. Townsend C.M., Beauchamp R.D., Evers B.M., and Mattox K.L. Sabiston Textbook of Surgery. The Biological Basics of Modern Surgical Practice. 16th ed. (2001), W. B. Saunders, Philadelphia, PA
2. Dixon J.M. Sentinel node biopsy. ed. In: Galimberti V., Gennari R., and Zerwes F. (Eds). Breast Cancer: Diagnosis and Management (2000), Elsevier Science, New York
3. Feig B.W., Berger D.H., and Fuhrman G.M. The M. D. Anderson Surgical Oncology Handbook. 3rd edition (2004), Lippincott, Williams, and Wilkins, Baltimore, Maryland
4. Rovera F., Frattini F., Marelli M., et al. Axillary sentinel node biopsy: an overview. Int J Surg suppl 1 (2008) S109-S112
5. Chen A.Y., Halpern M.T., Schrag N.M., et al. Disparities and trends in sentinel node biopsy among early-stage breast cancer patients (1998-2005). J Natl Cancer Inst 100 (2008) 462-474
6. Cody III H.S. Clinical aspects of sentinel node biopsy. Breast Cancer Res 3 (2001) 104-108
7. Stell V.H., Flippo-Morton T.S., Norton H.J., et al. Effect of intraoperative radiocolloid injection on sentinel lymph node biopsy in patients with breast cancer. Ann Surg Oncol 16 (2009) 2300-2304
8. McMasters K.M., Wong S.L., Martin II R.C., et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233 (2001) 676-687
9. Koukouraki S., Sanidas E., Askoxilakis J., et al. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?. Nucl Med Commun 30 (2008) 48-53
10. Pan W.R., Rozen W.M., Stella D.L., et al. A three-dimensional analysis of the lymphatics of a bilateral breast specimen: a human cadaveric study. Clin Breast Cancer 9 (2009) 86-91
11. Fowler J.C., Solanki C.K., Ballinger J.R., et al. Axillary lymph node drainage pathways from intradermal and intraparenchymal breast planes. J Surg Res (2009) Epub ahead of print.
12. Thompson M., Korourian S., Henry-Tillman R., et al. Intraoperative radioisotope injection for sentinel lymph node biopsy. Ann Surg Oncol 15 (2008) 3216-3221
13. Bleicher R.J., O'Sullivan M.J., Ciocca V., et al. A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer: a predictor of nodal metastasis location. Cancer 113 (2008) 3100-3107
14. Mathelin C., Salvador S., Bekaert V., et al. A new intraoperative gamma camera for the sentinel lymph node procedure in breast cancer. Anticancer Res 28 (2008) 2859-2864
15. Gui G.P., Joubert D.J., Reichert R., et al. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer. Eur J Surg Oncol 31 (2005) 707-714
16. van der Ploeg I.M., Nieweg O.E., Kroon B.B., et al. The yield of SPECT/CT for anatomical lymphatic mapping in patients with breast cancer. Eur J Nucl Med Mol Imaging 36 (2009) 903-909
17. Gauthier T., Mollard J., Fermeaux V., et al. Axillary recurrence after negative sentinel lymph node biopsy under local anesthesia in breast cancer. Eur J Surg Oncol 35 (2008) 464-468
18. Teknos D., Ramcharan A., and Oluwole S.F. Pulmonary edema associated with methylene blue dye administration during sentinel lymph node biopsy. J Natl Med Assoc 100 (2008) 1483-1484
19. Liang M.I., and Carson III W.E. Biphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy. World J Surg Oncol 6 (2008) 79
20. Lanitis S., Filippakis G., Sidhu V., et al. Atypical anaphylactic reaction to patent blue during sentinel lymph node biopsy for breast cancer. Ann R Coll Surg Engl 90 (2008) 338-339
21. Kaufman G., Guth A.A., Pachter H.L., et al. A cautionary tale: anaphylaxis to isosulfan blue dye after 12 years and 3339 cases of lymphatic mapping. Am Surg 74 (2008) 152-155
22. East J.M., Valentine C.S., Kanchev E., et al. Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis. BMC Surg 9 (2009) 2
23. Davis K.G., and Schriver J.P. Prevalence of teaching sentinel lymph node biopsy for breast cancer in general surgery residency programs. Curr Surg 59 (2002) 420-422
24. Teilum D., Kroman N., and Friis E. (Sentinel node technique in local relapse after breast-conserving surgery). Ugeskr Laeger 170 (2008) 3136-3137
25. Ruano R., Ramos M., Garcia-Talavera J.R., et al. Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer. Eur J Nucl Med Mol Imaging 35 (2008) 1299-1304
26. Karam A., Stempel M., Cody III H.S., et al. Reoperative sentinel lymph node biopsy after previous mastectomy. J Am Coll Surg 207 (2008) 543-548
27. Palit G., Jacquemyn Y., and Tjalma W. Sentinel node biopsy for ipsilateral breast cancer recurrence: A review. Eur J Gynaecol Oncol 29 (2008) 565-567
28. Tausch C., Konstantiniuk P., Kugler F., et al., Austrian Sentinel Node Study Group. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol 15 (2008) 3378-3383
29. Xing Y., Foy M., Cox D.D., et al. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93 (2006) 539-546
30. Hino M., Sano M., Sato N., et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer. Surg Today 38 (2008) 585-591
31. Hidar S., Bibi M., Gharbi O., et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer. Int J Surg 7 (2009) 272-275
32. Dupont E.L., Kuhn M.A., McCann C., et al. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 180 (2000) 274-277
33. Boughey J.C., Cormier J.N., Xing Y., et al. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer 110 (2007) 2542-2550
34. McLaughlin S.A., Stempel M., Morris E.A., et al. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?. Cancer 112 (2008) 1214-1221
35. Soran A., Falk J., Bonaventura M., et al. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy?. Magee-Womens Hospital experience. Ann Surg Oncol 14 (2007) 646-651
36. Papa M.Z., Zippel D., Kaufman B., et al. Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer. J Surg Oncol 98 (2008) 403-406
37. Menard J.P., Extra J.M., Jacquemier J., et al. Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy. Eur J Surg Oncol 35 9 (2009) 916-920
38. Iwase H., Yamamoto Y., Kawasoe T., et al. Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment. Surg Today 39 (2009) 374-380
39. Porembka M.R., Abraham R.L., Sefko J.A., et al. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data. Ann Surg Oncol 15 (2008) 2709-2719
40. Polom K., Murawa D., Wasiewicz J., et al. The role of sentinel node biopsy in ductal carcinoma in situ of the breast. Eur J Surg Oncol 35 (2009) 43-47
41. Takács T., Paszt A., Szentpáli K., et al. Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer. Pathol Oncol Res (2008) Epub ahead of print.
42. van la Parra R.F., Ernst M.F., Barneveld P.C., et al. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast. Eur J Surg Oncol 34 (2008) 631-635
43. Jatoi I. Internal mammary sentinel nodes in primary breast cancer. Curr Med Res Opin 19 (2003) 567-569
44. Coombs N.J., Boyages J., French J.R., et al. Internal mammary sentinel nodes: ignore, irradiate or operate?. Eur J Cancer 45 (2008) 789-794
45. Schwartz S.I., Shires G.T., Spencer F.C., et al. Principles of Surgery. 7th ed. (1999), McGraw-Hill Health Professions Division, New York vol 1.
46. Rovera F., Frattini F., Marelli M., et al. Axillary sentinel lymph node biopsy: an overview. Int J Surg 6 suppl 1 (2008) S109-S112
47. Hong J., Choy E., Soni N., et al. Extra-axillary sentinel node biopsy in the management of early breast cancer. Eur J Surg Oncol 31 (2005) 942-948
48. Feng J., and Bernacki E.G. Intraoperative cytologic evaluation of sentinel lymph nodes in patients with breast carcinoma by scrape preparation. Diagn Cytopathol 36 (2008) 790-793
49. van de Vrande S., Meijer J., Rijnders A., et al. The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer. Eur J Surg Oncol 35 (2009) 276-280
50. Piato J.R., Pincerato K.M., Gomes V.C., et al. (Occult metastasis in sentinel lymph node in early-stage breast cancer). Rev Bras Ginecol Obstet 30 (2008) 432-436
51. Adams S.U. Ortho-Clinical diagnostics. http://www.orthoclinical.com/en-us/Pages/Home.aspx
52. Julian T.B., Blumencranz P., Deck K., et al. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol 26 (2008) 3338-3345
53. Perhavec A., Besić N., Hocevar M., et al. Touch imprint cytology of the sentinel lymph nodes might not be indicated in early breast cancer patients with ultrasonically uninvolved axillary lymph nodes. Ann Surg Oncol 15 (2008) 2257-2262
54. Gawlick U., Mone M.C., Hansen H.J., et al. Selective use of intraoperative sentinel lymph node pathological evaluation in breast cancer. Am J Surg 196 (2008) 851-855 ; discussion, 855-856.
55. Gill G., and The SNAC Trial Group of the Royal Australasian College of Surgeons (RACS) and NHMRC Clinical Trials Centre. Sentinel-lymph-node-based management or routine axillary clearance?. One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): A Randomized controlled surgical trial. Ann Surg Oncol 16 (2009) 266-275
56. Lo Y.F., Hsueh S., Ma S.Y., Chen S.C., et al. Radioguided sentinel lymph node biopsy in early breast cancer: experience at Chang Gung Memorial Hospital. Chang Gung Med J 29 (2006) 458-467
57. Holwitt D.M., Gillanders W.E., Aft R.L., et al. Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: Low false-negative rate and lack of axillary recurrence. Am J Surg 196 (2008) 562-565
58. Schwartz G.F., Krill L.S., Palazzo J.P., et al. Value of intraoperative examination of axillary sentinel nodes in carcinoma of the breast. J Am Coll Surg 207 (2008) 758-762
59. Lynch M.A., Jackson J., Kim J.A., et al. Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer. Surgery 144 (2008) 525-531 ; discussion, 531-532.
60. van Deurzen C.H., Borgstein P.J., and van Diest P.J. In-transit lymph node metastases in breast cancer: A possible source of local recurrence after sentinel node procedure. J Clin Pathol 61 (2008) 1314-1316
61. Unal B., Gur A.S., Kayiran O., et al. Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system. Int J Clin Pract 62 (2008) 1785-1791
62. Pugliese M.S., Beatty J.D., Tickman R.J., et al. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories. Ann Surg Oncol 16 (2009) 113-120
63. Goyal A., and Mansel R.E. Recent advances in sentinel lymph node biopsy for breast cancer. Curr Opin Oncol 20 (2008) 621-626
64. Christiansen P., Friis E., Balslev E., et al. Sentinel node biopsy in breast cancer: Five years experience from Denmark. Acta Oncol 47 (2008) 561-568
65. van Deurzen C.H., de Boer M., Monninkhof E.M., et al. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 100 (2008) 1574-1580
66. van der Heiden-van der Loo M., Bezemer P.D., Hennipman A., et al. Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol 32 (2006) 710-714
67. Del Bianco P., Zavagno G., Burelli P., et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: Results of the Sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34 (2008) 508-513
68. McLaughlin S.A., Wright M.J., Morris K.T., et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Objective measurements. J Clin Oncol 26 (2008) 5213-5219
69. Bulte C.S., van der Heiden-van der Loo M., and Hennipman A. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study. Eur J Surg Oncol 35 (2009) 25-31
70. Poletti P., Fenaroli P., Milesi A., et al. Axillary recurrence in sentinel lymph node-negative breast cancer patients. Ann Oncol 19 (2008) 1842-1846
71. Veronesi U., Galimberti V., Paganelli G., et al. Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer 45 (2009) 1381-1388
72. van Wely B.J., Smidt M.L., de Kievit I.M., et al. False-negative sentinel lymph node biopsy. Br J Surg 95 (2008) 1352-1355
73. Bergkvist L., de Boniface J., Jönsson P.E., et al. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish multicenter cohort study. Ann Surg 247 (2008) 150-156
74. Blanco I., Moriyón C., Santamaría L., et al. (Our experience of the clinical application of sentinel node biopsy in breast cancer). Cir Esp 82 (2007) 352-357
75. Zavagno G., Carcoforo P., Franchini Z., et al. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol 31 (2005) 715-720
76. Vanderveen K.A., Schneider P.D., Khatri V.P., et al. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Ann Surg Oncol 13 (2006) 1450-1456
77. Langer I., Guller U., Hsu-Schmitz S.F., et al. Sentinel lymph node biopsy is associated with improved survival compared to level I and II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 35 (2009) 805-813